{"id":268492,"date":"2026-06-01T12:07:29","date_gmt":"2026-06-01T08:07:29","guid":{"rendered":"https:\/\/abcmedia.am\/?p=268492"},"modified":"2026-06-01T12:42:05","modified_gmt":"2026-06-01T08:42:05","slug":"new-drug-doubles-survival-time-for-pancreatic-cancer-patients","status":"publish","type":"post","link":"https:\/\/abcmedia.am\/en\/news\/268492\/","title":{"rendered":"New drug doubles survival time for pancreatic cancer patients"},"content":{"rendered":"\n

A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer, the BBC<\/a> writes.<\/p>\n

The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers.<\/p>\n

It helps prevent the spread of cancer by locking onto and shutting off the mutated KRAS gene, which is in more than 90% of pancreatic tumours and spurs cancer growth.<\/p>\n

The trial, which included 500 patients in North America, Europe, and Asia, found the average survival time for patients on chemotherapy was 6.6 months, compared with 13.2 months for patients on daraxonrasib. It also caused fewer side-effects.<\/p>\n

The trial, led by American scientists and presented at the American Society of Clinical Oncology annual meeting in Chicago, involved 248 patients who were given daraxonrasib and 252 who were given chemotherapy.<\/p>\n<\/body><\/html>\n","protected":false},"excerpt":{"rendered":"

A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer, the BBC writes. The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers. It helps prevent the […]<\/p>\n","protected":false},"author":7,"featured_media":268446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2,47,110],"tags":[],"class_list":["post-268492","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-society","category-health"],"acf":[],"_links":{"self":[{"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/posts\/268492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/comments?post=268492"}],"version-history":[{"count":1,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/posts\/268492\/revisions"}],"predecessor-version":[{"id":268496,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/posts\/268492\/revisions\/268496"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/media\/268446"}],"wp:attachment":[{"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/media?parent=268492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/categories?post=268492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abcmedia.am\/en\/wp-json\/wp\/v2\/tags?post=268492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}